It was ironic to hear RECOVER presenters bemoaning the fact that they couldnt take the normal approach to treatments because we dont know the molecular pathways, given that RECOVER has spent the vast majority of its almost $2 billion on observational studies, which will never shed any light on them
The STEP2 trial compared Ozempic to placebo in 1,200 individuals with type 2 diabetes and obesity
Since 2000, drug-related deaths have claimed more than a million American lives
It is essential to assess each case thoroughly to identify the underlying cause
In SV40-MES 13 cells, HMGB1 (high-mobility group box-1) has been recognized as a valuable factor of ferroptosis based on the Nrf2/HO-1 signaling pathway, proposing that HMGB1 is a new target for the treatment of DN [157]
Unlimited Support: Our team is here for you every step of the way, offering guidance and answering questions as they arise